Literature DB >> 22127145

Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control.

Laure Chagniel1, Christine Robitaille, Christopher Lacharité-Mueller, Geneviève Bureau, Michel Cyr.   

Abstract

Recent findings suggest that the neurotransmitter dopamine (DA) system plays a role in motor control and the acquisition of habits and skills. However, isolating DA-mediated motor learning from motor performance remains challenging as most studies include often severely DA-depleted mice. Using the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we investigated the effect of various degrees of DA-depletion in mice on three tests of motor behaviors: the accelerating rotarod, wire suspension and pole tests. Three protocols were performed to decrease DA synthesis to various extents: 4 injections (i.p.) of 9 mg/kg in 1 day; 4 injections (i.p.) of 15 mg/kg in 1 day; or 5 injections (s.c.) of 30 mg/kg in 5 days. Severity of DA-depletion was assessed by the evaluation of tyrosine hydroxylase (TH) and dopamine transporter levels in the striatum using the Western blot technique. Mice were gathered into four different groups according their TH levels: mild, moderate, marked and severe. In these mice, the general motor abilities such as coordination, motion speed and muscular strength were relatively intact whereas impaired acquisition of skilled behavior occurred in mice with marked and severe reduction in TH levels. Marked and severely DA-depleted mice exhibited lower scores within the first trials of the first training day as well as a much slower progression in the following days on the accelerating rotarod. Based on these results, we conclude that the learning of a skilled behavior is more vulnerable to DA depletion than the DA-mediated control of motor activity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127145     DOI: 10.1016/j.bbr.2011.11.019

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

1.  MANF improves the MPP+/MPTP-induced Parkinson's disease via improvement of mitochondrial function and inhibition of oxidative stress.

Authors:  Yigang Liu; Jingxing Zhang; Ming Jiang; Qiong Cai; Jianmin Fang; Lingjing Jin
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

2.  GABAergic imbalance is normalized by dopamine D1 receptor activation in the striatum contralateral to the cortical injury in motor deficit-recovered rats.

Authors:  Arturo Gálvez-Rosas; Alberto Avila-Luna; Margarita Valdés-Flores; Sergio Montes; Antonio Bueno-Nava
Journal:  Psychopharmacology (Berl)       Date:  2019-03-11       Impact factor: 4.530

3.  A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.

Authors:  Danielle A Simmons; Nadia P Belichenko; Tao Yang; Christina Condon; Marie Monbureau; Mehrdad Shamloo; Deqiang Jing; Stephen M Massa; Frank M Longo
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

4.  Dopamine D1 receptor activation maintains motor coordination and balance in rats.

Authors:  Alberto Avila-Luna; Arturo Gálvez-Rosas; Alfredo Durand-Rivera; Laura-Elisa Ramos-Languren; Camilo Ríos; José-Antonio Arias-Montaño; Antonio Bueno-Nava
Journal:  Metab Brain Dis       Date:  2017-10-19       Impact factor: 3.584

5.  Dicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival.

Authors:  Xueyan Pang; Eric M Hogan; Alison Casserly; Guangping Gao; Paul D Gardner; Andrew R Tapper
Journal:  Mol Cell Neurosci       Date:  2013-10-31       Impact factor: 4.314

6.  MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease.

Authors:  Young Cheul Chung; Yoon-Seong Kim; Eugene Bok; Tae Young Yune; Sungho Maeng; Byung Kwan Jin
Journal:  Mediators Inflamm       Date:  2013-06-19       Impact factor: 4.711

7.  Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.

Authors:  Isabelle St-Amour; Mélanie Bousquet; Isabelle Paré; Janelle Drouin-Ouellet; Francesca Cicchetti; Renée Bazin; Frédéric Calon
Journal:  J Neuroinflammation       Date:  2012-10-09       Impact factor: 8.322

8.  Regulation of tyrosine phosphatase STEP61 by protein kinase A during motor skill learning in mice.

Authors:  Laure Chagniel; Yan Bergeron; Geneviève Bureau; Guy Massicotte; Michel Cyr
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

9.  Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson's Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model.

Authors:  Élise Pépin; Tim Jalinier; Guillaume L Lemieux; Guy Massicotte; Michel Cyr
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.